CVS Group plc
CVSGF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -2.38 | -0.06 | 0.15 | -0.74 |
| FCF Yield | 4.68% | 4.04% | 0.00% | 1.77% |
| EV / EBITDA | 11.51 | 17.83 | 16.35 | 44.85 |
| Quality | ||||
| ROIC | 4.79% | 2.88% | 2.39% | 1.88% |
| Gross Margin | 35.68% | 43.50% | 41.86% | 88.05% |
| Cash Conversion Ratio | 3.93 | 3.42 | – | 2.70 |
| Growth | ||||
| Revenue 3-Year CAGR | 14.59% | 8.84% | 9.50% | 9.43% |
| Free Cash Flow Growth | 72.29% | 0.00% | -100.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 2.99 | 5.66 | 4.22 | 6.70 |
| Interest Coverage | 4.94 | 2.93 | 8.73 | 1.52 |
| Efficiency | ||||
| Inventory Turnover | 13.14 | 6.37 | 5.68 | 6.62 |
| Cash Conversion Cycle | 7.01 | 10.52 | 6.16 | 27.30 |